§ 341.18 Expectorant active ingredient.
Current through Sep 8, 2026 · Read all of Part 341
The active ingredient of the product is guaifenesin when used within the dosage limits established in § 341.78(d).
[54 FR 8509, Feb. 28, 1989]
Current through Sep 8, 2026 · Read all of Part 341
The active ingredient of the product is guaifenesin when used within the dosage limits established in § 341.78(d).
[54 FR 8509, Feb. 28, 1989]
← § 341.16 Bronchodilator active ingredients.§ 341.20 Nasal decongestant active ingredients. →